CG Oncology Stock (NASDAQ: CGON) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 640.677K |
Day Range | - - - |
52 Wk Range | 25.770 - 50.230 |
Market Cap | $1.981B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 40 |
Short Interest | 3.56% |
Days to Cover | 6.09 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of CG Oncology (NASDAQ: CGON) through any online brokerage.
Other companies in CG Oncology’s space includes: Syndax Pharmaceuticals (NASDAQ:SNDX), Fusion Pharmaceuticals (NASDAQ:FUSN), Protagonist Therapeutics (NASDAQ:PTGX), Agios Pharmaceuticals (NASDAQ:AGIO) and Inhibrx (NASDAQ:INBX).
The latest price target for CG Oncology (NASDAQ: CGON) was reported by Goldman Sachs on Tuesday, May 14, 2024. The analyst firm set a price target for 50.00 expecting CGON to rise to within 12 months (a possible 68.18% upside). 11 analyst firms have reported ratings in the last year.
The stock price for CG Oncology (NASDAQ: CGON) is $29.73 last updated May 20, 2024 at 5:21 PM EDT.
There are no upcoming dividends for CG Oncology.
CG Oncology’s Q2 earnings are confirmed for Friday, August 2, 2024.
There is no upcoming split for CG Oncology.
CG Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.